A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with i
| Image |  |
|---|---|
| Description | scientific article published on 18 June 2014 |
| Author/s |
author: Einat Brill-Almon Raul Chertkoff Ari Zimran Gregory M Pastores |
| Publication date | June 18, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |